Hypoxia inducible factor pathway inhibitors as anticancer therapeutics

SK Burroughs, S Kaluz, D Wang, K Wang… - Future medicinal …, 2013 - Taylor & Francis
Hypoxia is a significant feature of solid tumor cancers. Hypoxia leads to a more malignant
phenotype that is resistant to chemotherapy and radiation, is more invasive and has greater …

Hypoxia‐inducible factor‐1 (HIF‐1) inhibitors from the last decade (2007 to 2016): A “structure–activity relationship” perspective

D Bhattarai, X Xu, K Lee - Medicinal research reviews, 2018 - Wiley Online Library
Tumor hypoxia is a common feature in most solid tumors and is associated with
overexpression of the hypoxia response pathway. Overexpression of the hypoxia‐inducible …

Targeting protein–protein interactions in the HIF system

SE Wilkins, MI Abboud, RL Hancock… - …, 2016 - Wiley Online Library
Animals respond to chronic hypoxia by increasing the levels of a transcription factor known
as the hypoxia‐inducible factor (HIF). HIF upregulates multiple genes, the products of which …

Biology of advanced uveal melanoma and next steps for clinical therapeutics

JJ Luke, PL Triozzi, KC McKenna… - Pigment cell & …, 2015 - Wiley Online Library
Uveal melanoma is the most common intraocular malignancy although it is a rare subset of
all melanomas. Uveal melanoma has distinct biology relative to cutaneous melanoma, with …

Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth

S Kaluz, Q Zhang, Y Kuranaga, H Yang, S Osuka… - Oncogene, 2021 - nature.com
Uveal melanoma (UM) is the most prevalent primary intraocular malignancy in adults, and
patients that develop metastases (~ 50%) survive< 1 year, highlighting the urgent need for …

Modulating the masters: chemical tools to dissect CBP and p300 function

ME Breen, AK Mapp - Current opinion in chemical biology, 2018 - Elsevier
Dysregulation of transcription is found in nearly every human disease, and as a result there
has been intense interest in developing new therapeutics that target regulators of …

Arylsulfonamide 64B inhibits hypoxia/HIF-induced expression of c-Met and CXCR4 and reduces primary tumor growth and metastasis of uveal melanoma

L Dong, S You, Q Zhang, S Osuka, NS Devi… - Clinical Cancer …, 2019 - AACR
Purpose: Uveal melanoma (UM) is the most prevalent and lethal intraocular malignancy in
adults. Here, we examined the importance of hypoxia in UM growth and tested the antitumor …

Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP

S Yin, S Kaluz, NS Devi, AA Jabbar… - Clinical Cancer …, 2012 - AACR
Purpose: The hypoxia-inducible factor-1 (HIF-1) plays a critical role in tumor adaptation to
hypoxia, and its elevated expression correlates with poor prognosis and treatment failure in …

Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy

J Li, W Xi, X Li, H Sun, Y Li - Bioorganic & Medicinal Chemistry, 2019 - Elsevier
Hypoxia is a common characteristic of many types of solid tumors and is associated with
tumor propagation, malignant progression, and resistance to anti-cancer therapy. HIF-1 …

Design and in Vitro Activities of N-Alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, Novel, Small-Molecule Hypoxia Inducible Factor-1 …

J Mun, AA Jabbar, NS Devi, S Yin, Y Wang… - Journal of medicinal …, 2012 - ACS Publications
The hypoxia inducible factor (HIF) pathway is an attractive target for cancer, as it controls
tumor adaptation to growth under hypoxia and mediates chemotherapy and radiation …